期刊文献+

大黄素对CT26结肠癌小鼠调节性T细胞功能的影响 被引量:9

Effect of emodin on Treg cells function in a mouse model of CT26 colon cancer
下载PDF
导出
摘要 目的:探讨大黄素对CT26结肠癌小鼠调节性T细胞免疫抑制功能的影响。方法:CT26结肠癌小鼠分为阴性对照组、大黄素治疗组和荷瘤模型组,给药14 d,分别检测以下指标:小鼠不同组织T细胞IFN-γ的分泌、效应细胞CD8+CD3+T细胞的比例、血清细胞因子IFN-γ、TNF-β1、IL-10的水平、不同组织CD4+CD25+Tregs IL-10的分泌。结果:大黄素明显升高CD8+CD3+T细胞在肿瘤局部的比例(P<0.05);大黄素显著提高外周血和淋巴结中T细胞分泌IFN-γ的能力(P<0.05);大黄素显著降低IFN-γ、TNF-β1、IL-10在血清中的水平(P<0.01);大黄素有抑制CD4+CD25+Tregs分泌IL-10的作用(P<0.01)。结论:大黄素可能通过影响Tregs的免疫抑制功能发挥抗肿瘤的作用。 Objective To investigate the effect of emodin on immune suppression function of regulatory T cells in a mouse model of CT26 colon cancer. Methods Twenty-four mice were divided into the negative control group, the emodin group and the tumor group. The populations of CD8+CD3+T cells, the T cells producing IFN-γ/ and the CD4+CD25+/Tregs secreting IL-10 in different mouse tissues were detected by flow cytometry. Levels of IFN-γ, TNF- β1 and IL-10 in serum were determined by ELISA. Results Emodin could significantly increase the percent of CD8+CD3+ cells in tumor (P 〈 0.05) and improve the ability of IFN-γ, secretion in T cells from peripheral blood and lymph nodes (P 〈 0.05). Emodin could reduce the levels of IFN-γ, TNF-β1 and IL-10 in the serum (P 〈 0.01) and inhibit IL-10 secretion in CD4+CD25+ Tregs (P 〈 0.01). Conclusion Emodin possesses the antitumor effect by affecting the immunosuppressive function of Tregs cells.
出处 《实用医学杂志》 CAS 北大核心 2014年第15期2377-2380,共4页 The Journal of Practical Medicine
基金 广东省医学科学技术研究基金项目(编号:A2013145) 广东省中医药局建设中医药强省立项资助科研课题(编号:20121104) 广东食品药品职业学院自然科学研究项目(编号:2012YZ001)
关键词 结肠肿瘤 大黄素 CT26结肠癌 调节性T细胞 Colonic neoplasms Emodin CT26 colon cancer cells Regulatory T cells
  • 相关文献

参考文献14

  • 1Alexander HK, Wahl LM. Self-tolerance and autoimmunity in a regulatory T cell model [J ]. Bull Math Biol, 2011,73 ( 1 ) : 33- 71.
  • 2Sojka DK, Huang YH, Fowell DJ. Mechanisms of regulatory T-cell suppression-a diverse arsenal for a moving target [J].Immunology, 2008,124( 1 ) : 13-22.
  • 3Srinivas G, Babykutty S, Sathiadevan PP, et al. Molecular mechanism of emodin action : transition from laxative ingredient to an antitumor agent [J]. Med Res Rev, 2007,27(5):591- 608.
  • 4Lin SY, Lai WW, Ho CC, et al.Emodin induces apoptosis of human tongue squamous cancer SCC-4 cells through reactive oxygen species and mitechondria-dependent pathways [J]. Anticancer Res, 2009,29( 1 ) : 327-335.
  • 5Ok S, Kim SM, Kim C, et al. Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4 [J ]. Immunopharmacol Immunotoxicol, 2012,34(5) :768-778.
  • 6阮志燕,王培训,邓向亮,王丽虹,周联.大黄素影响调节性T细胞迁徙与抑制小鼠结肠癌发展相关性研究[J].广州中医药大学学报,2013,30(4):529-532. 被引量:4
  • 7Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J]. Nat Med, 2004,10(9) :942- 949.
  • 8Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance [J]. Cell, 2008,133(5) :775-787.
  • 9Jarnicki AG, Lysaght J, Todryk S, et al. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4^+ and CD8^+ regulatory T cells [J]. J Immunol, 2006,177(2) :896-904.
  • 10Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus [ J ]. Cell, 2003,113 (6) : 685-700.

二级参考文献22

  • 1Ok S, Kim S M, Kim C, et al. Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4[J]. Immunopharmacol Immunotoxicol, 2012, 34 (5): 768.
  • 2Mailloux A W, Young M R. Regulatory T-cell trafficking: from thymic development to tumor-induced immune suppression [J].Crit Rev Immunol, 2010, 30 (5): 435.
  • 3Hoffman 1: A, Hansen W P. Immunofluorescent analysis of blood cells by flow cytometry [J]. Int J Immunopharmacol, 1981, 3 (3): 249.
  • 4Thornton A M, Shevaeh E M. Suppressor effector function of CD4+CD25+ immunoregulatory T ceils is antigen nonspeeific [J]. J Immunol, 2000, 164 (1): 183.
  • 5Fu J, Xu D, Liu Z, et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellulm" carcinoma patients[J]. Gastroenterology, 2007, 132 (7) : 2328.
  • 6Hiraoka N, Onozato K, Kosuge T, et al. Prevalence of FOXP3: regulatory T cells increases during the progression of pancreatic duetal adenocareinoma and its premaliguant lesions[J]. Clin CancerRes, 2006, 12 (18): 5423.
  • 7Wolf D, Wolf A M, Rumpold H, et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer [J]. Clin Cancer Res, 2005, 11 (23): 8326.
  • 8Steitz J, Bruck J, Lenz J, et al. Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8 (+) T-cell-dependent immune defense of BI6 melanoma[J]. Cancer Res, 2001, 61 (24): 8643.
  • 9Wang H Y, Peng G, Guo Z, et al. Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor ceils byantigen-specific CD4: regulatory T cells[J]. J Immunol, 2005, 174 (5): 2661.
  • 10Ormandy L A, Hillemann T, Wedemeyer H, et al. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma[J]. Cancer Res, 2005, 65 (6): 2457.

共引文献6

同被引文献46

引证文献9

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部